Cellular response to purine-containing compound

pathway activity — cross-omics
GO:0071415Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Cellular response to purine-containing compound pathway is significantly associated with the RNA expression of multiple genes, with the HNSC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are GCNT3, FBXO5, and FOXA1, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Cellular response to purine-containing compound activity versus GCNT3 in HNSC (Pearson r = -0.15).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCGCNT3 →-1.284-0.606.001.00935
BRCAFBXO5 →+0.524+0.157<.001<.00134
BRCAFOXA1 →-2.444-0.231<.001<.00134
BRCAARHGAP32 →-0.790-0.180.003.00134
BRCATMEM45B →-1.550-0.196<.001<.00134
BRCAFAM174B →-0.700-0.145<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0071415 vs GCNT3 — HNSC

Per-sample scatter of Cellular response to purine-containing compound activity vs GCNT3 in HNSC.

Explore this scatter interactively →

Exploration